Zur Rose Group AG
SIX:ROSE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its Industry Average (15.1), the stock would be worth CHf-143.19 (543% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -3.4 | CHf32.3 |
0%
|
| Industry Average | 15.1 | CHf-143.19 |
-543%
|
| Country Average | 19.5 | CHf-185.64 |
-675%
|
Forward EV/EBIT
Today’s price vs future ebit
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| CH |
Z
|
Zur Rose Group AG
SIX:ROSE
|
374.9m CHF | -3.4 | -2.2 | |
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
71B ZAR | 15 | 21.9 | |
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
32B ZAR | 16.3 | 25.9 | |
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
10.4B USD | 5.1 | -1.6 | |
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
40.8B BRL | 17.4 | 30.7 | |
| JP |
|
Tsuruha Holdings Inc
TSE:3391
|
933.4B JPY | 14.1 | 21.9 | |
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
929.6B JPY | 9.8 | 16.6 | |
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
16.8B SAR | 19 | 20.2 | |
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
28.4B CNY | 10.1 | 17.3 | |
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
657.7B JPY | 15.3 | 34.3 | |
| JP |
S
|
Sugi Holdings Co Ltd
TSE:7649
|
612.8B JPY | 12.2 | 13.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.5 |
| Median | 19.5 |
| 70th Percentile | 25.3 |
| Max | 855.5 |
Other Multiples
Zur Rose Group AG
Glance View
Zur Rose Group AG engages in the operation of an e-commerce pharmacy. The company is headquartered in Frauenfeld, Thurgau and currently employs 2,131 full-time employees. The company went IPO on 2017-07-06. The firm focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The firm's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The firm operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.
